Kawata Kazuhito

カワタカズヒト | Kawata Kazuhito

Research theme for competitive and other funds (5)：

2022 - 2025 免疫監視機構に着目したインテグリン阻害剤によるNASH肝癌の新規治療戦略の創出
2022 - 2025 MAFLD合併原発性胆汁性胆管炎の病態解明と新規治療法の構築
2022 - 2025 免疫老化機構からの原発性胆汁性胆管炎の病態解明と新規治療基盤の創出
2017 - 2020 Elucidation of the effect of S1PR2 on the disease specificity and pathophysiology of primary biliary cholangitis and its application to therapy
2014 - 2017 Functional analysis of transcription factor Nrf2 and production of new therapy in primary biliary cirrhosis

Papers (86)：

Kazuhiro Nouso, Miwa Kawanaka, Hideki Fujii, Kazuya Kariyama, Hidenori Toyoda, Michihiro Iwaki, Hideki Hayashi, Satoshi Oeda, Hideyuki Hyogo, Asahiro Morishita, et al. Validation study of age-independent fibrosis score (Fibrosis-3 index) in patients with metabolic dysfunction-associated steatotic liver disease. Hepatology research : the official journal of the Japan Society of Hepatology. 2024
Tsubasa Tsutsumi, Takumi Kawaguchi, Hideki Fujii, Yoshihiro Kamada, Hirokazu Takahashi, Miwa Kawanaka, Yoshio Sumida, Michihiro Iwaki, Hideki Hayashi, Hidenori Toyoda, et al. Hepatic inflammation and fibrosis are profiles related to mid-term mortality in biopsy-proven MASLD: A multicenter study in Japan. Alimentary pharmacology & therapeutics. 2024
Takeshi Chida, Shinya Watanabe, Kazuyoshi Ohta, Hidenao Noritake, Masahiko Ito, Tetsuro Suzuki, Takafumi Suda, Kazuhito Kawata. Impact of amino acid substitutions in hepatitis C virus core region on the severe oxidative stress. Free radical biology & medicine. 2024. 212. 199-206
Ayaka Tanifuji, Satoko Ohfuji, Kosuke Matsumoto, Masanori Abe, Atsumasa Komori, Atsushi Takahashi, Kazuhito Kawata, Ken Sato, Satoru Joshita, Takeji Umemura, et al. Safety and effectiveness of SARS-CoV-2 vaccines for patients with intractable hepatobiliary diseases: A multicenter, questionnaire-based, cross-sectional study. Hepatology Research. 2024
Taeang Arai, Hirokazu Takahashi, Yuya Seko, Hidenori Toyoda, Hideki Hayashi, Kanji Yamaguchi, Michihiro Iwaki, Masato Yoneda, Toshihide Shima, Hideki Fujii, et al. Accuracy of the Enhanced Liver Fibrosis Test in Patients With Type 2 Diabetes Mellitus and Its Clinical Implications. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association. 2023

ｍore...

MISC (8)：

山下真帆, 川田一仁, 本多彰. 難治性肝疾患:病態解明と治療法確立に向けた基礎・臨床研究の最前線原発性胆汁性胆管炎の肝線維化進展モデルマウスの作成について. 日本消化器病学会雑誌. 2021. 118. 臨増総会. A206-A206
田中篤, 小森敦正, 阿部雅則, 稲生実枝, 浪崎正, 橋本直明, 川田一仁, 高橋敦史, 二宮匡史, 藤井英樹, et al. 日本人PBC患者の予後予測におけるGlobeスコア・UK-PBCスコアの妥当性の検証. 肝臓. 2018. 59. Suppl.1. A454-A454
Takeshi Chida, Masahiko Ito, Kazuhito Kawata, Yoshimasa Kobayashi, Tetsuro Suzuki. Role of CREBH activation induced by HCV infection in up-regulation of TGF-beta 2 expression and fibrogenesis. HEPATOLOGY. 2015. 62. 892A-892A
平出貴乗, 坂口孝宣, 木内亮太, 武田真, 柴崎泰, 森田剛文, 鈴木淳司, 川田一仁, 小林良正, 川原央好, et al. 10代に発症した肝間葉系過誤腫の1例. 肝臓. 2014. 55. 12. 756-763
Weici Zhang, Masanobu Tsuda, Guo-Xiang Yang, Koichi Tsuneyama, Yugo Ando, Kazuhito Kawata, Ogyi Park, Patrick S. Leung, Ross L. Coppel, Aftab A. Ansari, et al. Dissecting the Role of Il-12 in Autoimmune Cholangitis of dnTGF beta RII Mice. HEPATOLOGY. 2012. 56. 302A-302A

ｍore...

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page